Subbaramaiah Kotha, Benezra Robert, Hudis Clifford, Dannenberg Andrew J
Department of Medicine and the Weill Cornell Cancer Center, Weill Cornell Medical College, NY, NY 10065, USA.
J Biol Chem. 2008 Dec 5;283(49):33955-68. doi: 10.1074/jbc.M805490200. Epub 2008 Oct 8.
Cyclooxygenase-2 (COX-2) and Id-1 are overexpressed in a variety of human malignancies. Recently, each of these genes was found to play a role in mediating breast cancer metastasis to the lungs, but their potential interdependence was not evaluated. Hence, the main objective of the current study was to determine whether COX-2-derived prostaglandin (PGE(2)) activated Id-1 transcription, leading in turn to increased invasiveness of mammary epithelial cells. In MDA-MB-231 cells, treatment with PGE(2) induced Id-1, an effect that was mimicked by an EP(4) agonist. PGE(2) via EP(4) activated the epidermal growth factor receptor (EGFR) --> ERK1/2 pathway, which led to increased expression of Egr-1. PGE(2) stimulated EGFR signaling by inducing the release of amphiregulin, an EGFR ligand. The ability of PGE(2) to activate Id-1 transcription was mediated by enhanced binding of Egr-1 to the Id-1 promoter. Silencing of COX-2 or pharmacological inhibition of COX-2 led to reduced PGE(2) production, decreased Id-1 expression, and reduced migration of cells through extracellular matrix. A similar decrease in cell migration was found when Id-1 was silenced. The interrelationship between COX-2, PGE(2), Id-1, and cell invasiveness was also compared in nontumorigenic SCp2 and tumorigenic SCg6 mammary epithelial cells. Consistent with the findings in MDA-MB-231 cells, COX-2-derived PGE(2) induced Id-1, leading in turn to increased cell invasiveness. Taken together, these results suggest that PGE(2) via EP(4) activated the EGFR --> ERK1/2 --> Egr-1 pathway, leading to increased Id-1 transcription and cell invasion. These findings provide new insights into the relationship between COX-2 and Id-1 and their potential role in metastasis.
环氧化酶-2(COX-2)和Id-1在多种人类恶性肿瘤中过表达。最近,发现这两种基因在介导乳腺癌肺转移中均发挥作用,但它们之间潜在的相互依赖性尚未得到评估。因此,本研究的主要目的是确定COX-2衍生的前列腺素(PGE₂)是否激活Id-1转录,进而导致乳腺上皮细胞侵袭性增加。在MDA-MB-231细胞中,用PGE₂处理可诱导Id-1,这一效应可被EP₄激动剂模拟。PGE₂通过EP₄激活表皮生长因子受体(EGFR)→ERK1/2通路,导致Egr-1表达增加。PGE₂通过诱导双调蛋白(一种EGFR配体)的释放来刺激EGFR信号传导。PGE₂激活Id-1转录的能力是由Egr-1与Id-1启动子的结合增强介导的。COX-2的沉默或COX-2的药理学抑制导致PGE₂产生减少、Id-1表达降低以及细胞通过细胞外基质的迁移减少。当Id-1沉默时,细胞迁移也出现类似减少。在非致瘤性SCp2和致瘤性SCg6乳腺上皮细胞中也比较了COX-2、PGE₂、Id-1和细胞侵袭性之间的相互关系。与MDA-MB-231细胞中的发现一致,COX-2衍生的PGE₂诱导Id-1,进而导致细胞侵袭性增加。综上所述,这些结果表明PGE₂通过EP₄激活EGFR→ERK₁/₂→Egr-1通路,导致Id-1转录增加和细胞侵袭。这些发现为COX-2和Id-1之间的关系及其在转移中的潜在作用提供了新的见解。